| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
2 companies
Morabito Christopher is a Chief Medical Officer at Fulcrum Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 3 sells.
Estimated insider holdings value: $8K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | ATXS Astria Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 10,000 | $13.59 | $135,939.00 | -100% | -31.5% | -60.0% | |
| Jan 29, 2024 | ATXS Astria Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 10,000 | $11.14 | $111,364.40 | -100% | -24.3% | -38.0% | |
| Jun 28, 2021 | FULC Fulcrum Therapeutics, Inc. | Chief Medical Officer | Buy | 1,100 | $9.16 | $10,076.00 | New | +202.6% | -46.2% |